|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEWS
1Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire; 2State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China
Submitted 12 November 2008 ; accepted in final form 12 January 2009
ABSTRACT
The enzymes acyl-coenzyme A (CoA):cholesterol acyltransferases (ACATs) are membrane-bound proteins that utilize long-chain fatty acyl-CoA and cholesterol as substrates to form cholesteryl esters. In mammals, two isoenzymes, ACAT1 and ACAT2, encoded by two different genes, exist. ACATs play important roles in cellular cholesterol homeostasis in various tissues. This chapter summarizes the current knowledge on ACAT-related research in two areas: 1) ACAT genes and proteins and 2) ACAT enzymes as drug targets for atherosclerosis and for Alzheimer's disease.
acyl-coenzyme A:cholesterol acyltransferase inhibitors; atherosclerosis; Alzheimer's disease
This article has been cited by other articles:
![]() |
G. Xu, T. Watanabe, Y. Iso, S. Koba, T. Sakai, M. Nagashima, S. Arita, S. Hongo, H. Ota, Y. Kobayashi, et al. Preventive Effects of Heregulin-{beta}1 on Macrophage Foam Cell Formation and Atherosclerosis Circ. Res., August 28, 2009; 105(5): 500 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cheng Fat for life: new stories on old grease Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1181 - E1182. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |